Fondazione Salvatore Maugeri

What Fondazione Salvatore Maugeri does

Fondazione Salvatore Maugeri is an Italian private nonprofit foundation (Fondazione) established in 1965 by Salvatore Maugeri (1905-1985) in Pavia as the Fondazione Clinica del Lavoro, renamed in 1985 to its present form after its founder's death. Its statutory purpose is funding clinical and scientific research for the 'fragile patient' (paziente fragile), defined as patients with chronic respiratory, cardiovascular, and neurological conditions who require multidimensional, integrated care. The foundation channels charitable donations into three therapeutic-area research programs — Pneumology (COPD, asthma, sleep-disordered breathing, cystic fibrosis), Neuromotor Medicine (multiple sclerosis, Parkinson's, stroke, motor neuron disease rehabilitation), and Cardioangiology (heart failure, arrhythmias, post-ischemic cardiac care) — operating through a network of 18 clinical institutes under ICS Maugeri Spa Società Benefit, of which 9 carry the IRCCS (Istituti di Ricovero e Cura a Carattere Scientifico) designation granted by the Italian Ministry of Health.

The foundation's revenue model is entirely donation-based and operates under Italian fiscal frameworks, including the 5x1000 tax designation (signors allocate 0.5% of income tax via forms 730/UNICO/CUD to the foundation's tax code 00305700189), testamentary bequests, in-memory gifts, and direct donations that are tax-deductible up to 10% of declared income (max 70,000 euros annually) under Art.14 D.L. 35/2005, with full deductibility for corporate donations under DPCM 31/10/2016. It allocates approximately 3 million euros annually to ICS Maugeri institutes for the 2018-2020 funding triennium. The foundation holds no parent company, generates no commercial product revenue, is governed by a board led by President Gualtiero Brugger and Vice President Chiara Maugeri (granddaughter of the founder), and supports an ecosystem of partnerships with patient associations (A.N.N.A, Respiriamo Insieme, UILDM) and recurring annual events including Giornata Salvatore Maugeri (founded 1965). Go-to-market is community-led: awareness campaigns, donor drives, the annual Maugeri Day event, and earned-media coverage in regional and national Italian press support fundraising; ICS Maugeri Spa Benefit, spun off in 2016, is the operating entity running the clinical network while the foundation remains the funding and research-advocacy vehicle.

Name

Fondazione Salvatore Maugeri

Legal name

Fondazione Salvatore Maugeri Clinica del Lavoro e della Riabilitazione

Website

https://fsm.it

Company type

Private

Founded year

1965

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Fondazione Salvatore Maugeri is an Italian nonprofit foundation, founded in 1965 in Pavia, that funds clinical-scientific research across 18 ICS Maugeri institutes and 9 Ministry of Health–recognized IRCCS hospitals for fragile patients with chronic respiratory, neurological, and cardiovascular conditions.

Ownership category

akta.pro rank

Product category

Medical Research Foundation

NAICS

Voluntary Health Organizations (813212), Grantmaking Foundations (813211), Grantmaking and Giving Services (81321)

SIC

Services-Social Services (8300)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

Keywords

• Clinical research foundation
• Medical research funding
• Healthcare research programs
• Scientific research charity
• Biomedical research support

Headquarters

HQ city

Pavia

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

1. 5x1000 Tax Donations: Italian taxpayers can designate 0.5% of their income tax to the foundation by signing form 730/UNICO/CUD and providing the foundation's tax code (00305700189). This mechanism costs the donor nothing extra and generates funds for scientific research conducted at 18 Maugeri clinical institutes.
2. Testamentary Bequests: Individuals can include the foundation in their will, bequeathing real estate, movable property (paintings, jewelry, furniture, money, stocks, bonds), or life insurance policies. Testamentary provisions in favor of the foundation are tax-exempt. This provides long-term funding for fragile patient research.
3. In-Memory Donations: Donations made in memory of a deceased loved one, typically via bank transfer or credit card. The foundation acknowledges these donations with receipts for tax purposes.
4. Direct Research Funding Allocation: The foundation allocates approximately 3 million euros annually to fund clinical-scientific research at ICS Maugeri institutes, specifically targeting research focused on fragile patient care across three therapeutic areas.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Fondazione Salvatore Maugeri is an Italian nonprofit foundation that funds clinical and scientific research focused on the 'fragile patient', supporting patients with chronic respiratory, cardiovascular, and neurological diseases. It channels approximately 3 million euros annually into research programs (Pneumologia, Medicina Neuromotoria, Cardioangiologia) executed across 18 ICS Maugeri institutes, 9 of which carry IRCCS designation. Revenue comes entirely from charitable donations (5x1000 tax designations, testamentary bequests, in-memory gifts, and direct contributions).

Product overview

Fondazione Salvatore Maugeri is a unified foundation dedicated to financing scientific research focused on the 'fragile patient' concept. The organization operates through three main research programs in Pneumologia, Medicina Neuromotoria, and Cardioangiologia, funded through donations, 5x1000 tax designations, and testamentary bequests. The foundation supports Istituti Clinici Scientifici Maugeri (ICS Maugeri), which operates 18 clinical research institutes across Italy, 9 of which are recognized as IRCCS (Istituti di Ricovero e Cura a Carattere Scientifico). The foundation's mission centers on supporting patients with chronic conditions including respiratory diseases, neurological disorders, and cardiovascular diseases.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 18 research institutes and 1 environmental research center supported through foundation funding
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• Istituti Clinici Scientifici Maugeri Spa Società BenefitcoreStrategic or Co-development Partner · 1 January 2016The foundation's primary strategic partner is ICS Maugeri Spa Società Benefit, established in 2016 from the original institution founded by Salvatore Maugeri. The foundation funds clinical-scientific research conducted across ICS Maugeri's 18 institutes and 9 IRCCS facilities, with approximately 3 million euros allocated annually for the 2018-2020 period. This partnership enables translation of funded research into clinical applications for fragile patients.
• Patient Associations NetworkcoreStrategic or Co-development PartnerThe foundation maintains partnerships with patient associations including A.N.N.A (Associazione Nazionale Nutriti Artificialmente), Respiriamo Insieme, UILDM (Unione Italiana Lotta alle Distrofie Muscolari), and others. These associations participate in Maugeri Day events, contribute to research design discussions, and help advocate for fragile patient needs with institutional stakeholders. The foundation views patient associations as the natural 'trait d'union' between patients/families and the clinical-scientific community.

Scale indicators4 records

Recent moves6 records

Expansion highlights3 records

Direct peers

• Fondazione Telethon: Italian nonprofit foundation funding genetic and rare disease research. Direct peer to FSM as both are Italian grantmaking foundations raising funds via 5x1000 and donations to support clinical-scientific research.
• Fondazione Umberto Veronesi: Italian foundation funding clinical and scientific research, particularly oncology and chronic disease. Direct peer in funding model, 5x1000 reliance, and research mission.
• Fondazione Cariplo: Major Italian philanthropic foundation granting across health, research, and social services. Comparable as a large-scale Italian grantmaking organization with health research among its priorities.
• Compagnia di San Paolo: One of Italy's oldest philanthropic foundations, active in health and biomedical research funding. Comparable in operating model, geographic scope, and Italian donor/grantmaking dynamics.
• AIRC - Associazione Italiana per la Ricerca sul Cancro: Italy's primary cancer research grantmaking foundation. Direct peer sharing 5x1000 donation infrastructure, donor-base composition, and Italian grantmaking operating model.

Broad incumbents

• Howard Hughes Medical Institute: US-based nonprofit funding biomedical research and scientists. Comparable in operating model (research philanthropy) but materially larger scale and broader international scientific scope.
• Robert Wood Johnson Foundation: US foundation focused on health and healthcare research funding, particularly for vulnerable populations. Comparable in targeting chronic disease, health equity, and policy-impact research areas.
• Wellcome Trust: UK-based global charitable foundation funding biomedical research at much larger scale. Comparable as a health-research grantmaking foundation, though at substantially greater scale and geographic breadth.

Emerging players

• AISM - Associazione Italiana Sclerosi Multipla: Italian voluntary health organization funding multiple sclerosis research and patient services. Emerging/niche peer focused on one of FSM's three therapeutic pillars (neuromotor medicine).
• European Respiratory Society Foundation: European foundation funding respiratory medicine research. Comparable in funding pneumology research, one of FSM's three therapeutic focus areas, though smaller and pan-European in scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/c/IstitutiMaugeri
• Facebookfacebook.com/fondazionesalvatoremaugeri

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fondazione Salvatore Maugeri